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1 |  INTRODUCTION
Basal cell carcinoma is the most common skin cancer devel-
oping with various clinical and histologic features mostly in 
parts of the body exposed to UV‐light. Especially, the head 
and neck area is at risk. Some tumors develop in other parts 
of the body and may be part of a rare genetic syndrome.1
Therapy for locally advanced tumors includes surgical ex-
cisions with clear margins, laser or radiotherapy, and in ad-
vanced stages hedgehog pathway inhibitors, chemotherapy, 
and PDL‐1 immunotherapy in study protocols.2 Metastatic 
disease is unexpected and occurs according to the literature 
in only 0.025%‐0.55%.3
2 |  CASE REPORT
A 50‐year‐old otherwise healthy, nonimmunosuppressed 
male presented with several basal cell carcinomas and a ro-
dent ulcer, on his right shoulder, which was resected with 
clear margins followed by radiotherapy to the primary tumor 
site (Figure 1). Because of the size of the primary tumor, 
60 Gy was administered.
Initial ultrasound examination of the right axilla showed a 
lymph node measuring 1.8 × 1 × 1 cm, which was classified 
as unspecific lymph node enlargement. The patient presented 
3 years after initial treatment with sudden extensive lymph 
edema of the right upper extremity. On clinical examination, 
there was no lymph node enlargement palpable in the right 
axilla; however, ultrasound revealed only one suspicious 
lymph node (Figure 2).
Preoperative PET‐CT demonstrated two lymph nodes in 
the right axillary region and no evidence of further me-
tastasis (Figure 3). The patient was admitted for lymph-
adenectomy. Histologic examination revealed only one 
metastatic lymph node with basaloid differentiation and 
perinodular infiltration and one lymph node with un-
specific inflammation.
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Abstract
Basal cell carcinoma has a potential for early and late metastasis. Depending on 
the location of the primary site, the relevant lymphatic drainage routes have to be 
monitored. Regional lymph edema may be a first indicator for metastasizing disease.
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F I G U R E  1  Rodent ulcer of the right shoulder before surgical 
intervention
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In addition, final histopathology revealed carcinomatous 
hemangiosis. Because of previous radiotherapy, only lim-
ited additional radiotherapy with 50 Gy was feasible. After 
12 months, there is no sign of recurrent disease.
3 |  DISCUSSION
This is the first time that lymphedema of the upper ex-
tremity was indicative for metastatic disease in basal cell 
carcinoma. Since his first description in 1894 by Beadles 
et al, only approximately 400 cases of metastatic disease 
have been reported in the literature.4,5 It remains to be 
debated if the axilla lymph node at the time of primary 
treatment was involved by micrometastasis and included 
in the field of radiotherapy with later growth leading to 
lymphedema.
4 |  CONCLUSION
There are still ongoing discussions how to treat metasta-
sized basal cell carcinoma, thus making individual strategies 
necessary.
Individualized therapy depends on tumor load and local-
ization. Today's options include hedgehog inhibitors, surgery, 
and radiotherapy. Recent studies include PD1 inhibitor ther-
apy and tumor vaccination (Jäger, unpublished data/personal 
communication). In this case, lymphedema, as an early warn-
ing sign, led to timely intervention and further recurrence 
free survival till date.
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F I G U R E  2  Hypoechogenic, round‐
shaped lymph node in the right axillary 
region showing a loss of hilum with 
peripheral perfusion
F I G U R E  3  PET‐CT scan showing lymphedema of the right arm 
and localized FDG avidity in the right axilla
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